MedPath

Data collection of the patients receiving Grafalon® (Observational i.e. Non interventional)

Not Applicable
Conditions
Health Condition 1: N186- End stage renal disease
Registration Number
CTRI/2018/02/012258
Lead Sponsor
Cadila Healthcare Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Renal transplant patients receiving Grafalon® for prevention of acute transplant rejection.

Exclusion Criteria

Any reason which may prevent the doctor to enroll the patient in the registry.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath